M&A Corner
Sen. Elizabeth Warren Urges FTC to Review CVS’ Oak Street Health Deal03 Apr 2023
Senator Elizabeth Warren has written to the Federal Trade Commission (FTC) calling for the body to examine CVS Health’s planned... Continue Reading
|
Neurotechnology Company Cognito Therapeutics Scores $73M03 Apr 2023
Cognito Therapeutics, a Massachusetts-based startup developing a wearable device using visual and auditory stimulation to treat neurodegenerative disorders, has raised... Continue Reading
|
Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination03 Apr 2023
Graf Acquisition Corp. IV and biotech firm NKGen Biotech have signed a non-binding letter of intent to pursue a business... Continue Reading
|
Sona Nanotech Closes Acquisition of Siva Therapeutics, Plans For First Therapy Application for Colorectal Cancer03 Apr 2023
Sona Nanotech Inc. has announced the successful completion of its acquisition of Siva Therapeutics, Inc., which will allow the former... Continue Reading
|
Amryt Pharma Shareholders Approve Acquisition of Amryt Pharma By Chiesi Farmaceutici03 Apr 2023
Amryt Pharma has announced that all resolutions presented to shareholders at shareholder meetings held to consider and vote on the... Continue Reading
|
Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.03 Apr 2023
Bionoid Pharma has signed a letter of intent to acquire Global Alerts, a private company that provides a mass notification... Continue Reading
|
Mindstrong Sells Tech Assets to SonderMind, Shuts Down Operations03 Apr 2023
SonderMind, a digital mental health company, is acquiring Mindstrong’s technology assets, which includes some of the company’s tech-related workforce. The... Continue Reading
|
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company03 Apr 2023
Berkeley Lights has completed its acquisition of Isoplexis Corporation and the newly combined company has been renamed PhenomeX. The company’s... Continue Reading
|
Ally Biotech Announces Acquisition of Popular THC “Chill Pill” Soft Gel Cap Line from Desert Medical Campus, Inc.03 Apr 2023
Ally Biotech, a cannabinoid delivery solutions provider, has acquired the Chill Pill brand, which offers a range of soft gel... Continue Reading
|
Casi Pharmaceuticals Completes Redomiciliation Merger03 Apr 2023
CASI Pharmaceuticals has completed a redomiciliation merger to redomicile the company as a Cayman Islands company. Each outstanding share of... Continue Reading
|